NI
ELV icon

NDVR Inc’s Elevance Health ELV Stock Holding History

NDVR Inc’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-409
Closed -$212K – 96
2024
Q1 		$212K Buy
+409
New +$203K 0.2% 98

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

NDVR Inc's ELV Position: Q2 2024 in Review

NDVR Inc sold out of Elevance Health (ELV) in Q2 2024, closing a stake of 409 shares — an estimated $212K sold.

NDVR Inc first reported a position in ELV in Q1 2024 and held it in 1 quarter. The position peaked at $212K in Q1 2024. 1,705 funds tracked by Wall St. Rank hold ELV as of Q2 2024.

  • NDVR Inc reported no remaining Elevance Health position as of Q2 2024 after selling out during the quarter.
  • NDVR Inc sold 409 Elevance Health shares in Q2 2024, an estimated $212K.
  • NDVR Inc first reported a position in Elevance Health in Q1 2024 and held it in 1 quarter.
  • NDVR Inc's Elevance Health position peaked at $212K in Q1 2024.
  • 1,705 funds tracked by Wall St. Rank held Elevance Health as of Q2 2024.

Based on NDVR Inc's 13F filing for Q2 2024, filed 9 Aug 2024.